Drug
Dexketoprofen Tramadol Single Dose
Dexketoprofen Tramadol Single Dose: highest development phase Phase 3, developed by Menarini. 1 trial record tracked on RxWires.
- Highest phase
- Phase 3
- Developer
- Menarini
Trials
| Drug | Phase | Indication |
|---|---|---|
| Dexketoprofen/Tramadol-single dose NCT01904149 | Phase 3 | Acute Pain |
Latest
No recent events.
Follow Dexketoprofen Tramadol Single Dose on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.